A COMBINATION MEDICAMENT COMPRISING PHENYLEPHRINE AND PARACETAMOL

(19)

(11)

EP 2 830 605 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	08.11.2023 Bulletin 2023/45

(45)	Mention of the grant of the patent:
	27.09.2023 Bulletin 2023/39

(21)	Application number: 14746905.0

(22)	Date of filing: 07.01.2014

(51)

International Patent Classification (IPC):

A61K 31/137^(2006.01)
A61K 31/167^(2006.01)
A61P 11/02^(2006.01)

A61K 31/135^(2006.01)
A61P 11/00^(2006.01)
A61P 11/12^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 31/137; A61K 31/167; A61P 11/00; A61P 11/02; A61P 11/12

	C-Sets:
	A61K 31/137, A61K 2300/00; A61K 31/167, A61K 2300/00;

(86)	International application number:
	PCT/NZ2014/000001

(87)	International publication number:
	WO 2014/120021 (07.08.2014 Gazette 2014/32)

(54)	A COMBINATION MEDICAMENT COMPRISING PHENYLEPHRINE AND PARACETAMOL KOMBINATIONSMEDIKAMENT MIT PHENYLEPHRIN UND PARACETAMOL COMBINAISON MÉDICAMENTEUSE COMPRENANT LA PHÉNYLÉPHRINE ET LE PARACÉTAMOL

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

04.02.2013 NZ 60665913
02.05.2013 NZ 61013213
02.08.2013 NZ 61391813
20.11.2013 NZ 61802713

(43)	Date of publication of application:
	04.02.2015 Bulletin 2015/06

(73)	Proprietor: AFT Pharmaceuticals Limited
	Auckland 0622 (NZ)

(72)	Inventor:
	ATKINSON, Hartley Campbell Takapuna Auckland 0622 (NZ)

(74)	Representative: Arnold & Siedsma
	Bezuidenhoutseweg 57 2594 AC The Hague 2594 AC The Hague (NL)

(56)

References cited: :

WO-A1-2004/066978
WO-A2-2007/125501
US-A1- 2007 254 027
US-A1- 2010 136 107

WO-A1-2012/090218
US-A- 4 260 600
US-A1- 2009 230 013
US-A1- 2011 104 272

COLDREX P.E: 'Phenylephrine Sinus Tablets, Panadol Sinus Relief PE Tablets, Panadol Cold & Flu Max+Decongestant Tablets' NEW ZEALAND DATASHEET. 13 April 2012, XP055154372 Retrieved from the Internet: <URL:http://www.medsafe.goyt.87/profs/datas heet/c/Coldrextab.pdf> [retrieved on 2013-10-03]
'Trial from ANZCTR.' AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY. 15 August 2012, XP055154379 Retrieved from the Internet: <URL:https://www.anzctr.org.au/Trial/Regisi ration/TrialReview.aspx?id=362877> [retrieved on 2013-10-02]
ATKINSON HC ET AL.: 'Increased Phenylephrine Plasma Levels with Administration of Acetaminophen' THE NEW ENGLAND JOURNAL OF MEDICINE vol. 370, no. 12, 20 March 2014, pages 1171 - 1172, XP055154380

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).